Literature DB >> 2429541

Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.

S V Nash, J W Said.   

Abstract

Thirty-four gastroenteropancreatic (GEP) neuroendocrine tumors were evaluated for expression of epithelial (keratin, carcinoembryonic antigen [CEA] and neuroendocrine (neuron-specific enolase, chromogranin, bombesin) markers, and results were correlated with histologic patterns and histochemical staining. Tumors of mixed pattern (insular or trabecular with glandular areas) predominated. CEA localization corresponded to staining for mucin, with polarized apical or lumenal staining in glandular areas. Four trabecular midgut carcinoids, however, revealed diffuse cytoplasmic staining for CEA. Staining for keratin proteins was present in 68% of tumors. Bombesin immunoreactivity was demonstrated in 60% of GEP neuroendocrine tumors, indicating that bombesin positive metastatic tumors may not be predominantly of pulmonary origin, as previously suggested. Chromogranin was a sensitive marker for identifying normal gastrointestinal neuroendocrine cells that were not demonstrated by staining for neuron-specific enolase. Chromogranin was present in most neuroendocrine tumors, but was absent from three of five rectal carcinoids in keeping with the distinctive profile of hormonal and silver staining in these tumors. All GEP neuroendocrine neoplasms expressed both neuroendocrine and epithelial markers, supporting their derivation from endodermal epithelium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429541     DOI: 10.1093/ajcp/86.4.415

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.

Authors:  R Weiler; H Feichtinger; K W Schmid; R Fischer-Colbrie; L Grimelius; B Cedermark; M Papotti; G Bussolati; H Winkler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 2.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

3.  Small cell carcinoma of the gallbladder: report of two cases.

Authors:  S S Chuang; C N Lin; C H Chu; F F Chen
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.

Authors:  H Paraskevakou; A Saetta; K Skandalis; S Tseleni; A Athanassiadis; P S Davaris
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.

Authors:  C Bordi; F P Pilato; T D'Adda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

6.  Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.

Authors:  Dimitris Dimitroulopoulos; Dimitris Xynopoulos; Klisthenis Tsamakidis; Emmanouel Paraskevas; Athanassios Zisimopoulos; Efthymios Andriotis; Ekaterini Fotopoulou; Marios Kontis; Ioannis Paraskevas
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

7.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  N Durany; J Joseph; E Campo; R Molina; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.

Authors:  A G Fahrenkamp; C Wibbeke; G Winde; D Ofner; W Böcker; R Fischer-Colbrie; K W Schmid
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.